Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A spoon full of sugar helps inflammation go down

02.10.2003


Immune responses in the skin are mediated by effector T cells migrating to the inflamed and injured area. Inhibition of this migration has long been an attractive, though challenging, basis for anti-inflammatory treatment strategies. The migration is regulated, in part, by the proteins E-selectin and P-selectin present within endothelial cells of the skin. In a new study, Charles Dimitroff and colleagues from Harvard Medical School introduce a new strategy for the inhibition of selectin ligand production, which blocks E-selectin ligand expression and therefore ultimately prevents the development of contact hypersensitivity (CHS) responses.



Most interestingly, the agent used – a novel fluorosugar compound, 4-F-GlcNAc -– inhibited CHS responses with higher efficacy than glucocorticoids or calcineurin inhibitors currently available for the treatment of allergic skin reactions such as psoriasis and atopic dermatitis. The authors indicate that while a novel drug may still be some way off in terms of an available treatment, inhibition of selectin ligand activity has the potential for efficacy in both preventative and therapeutic applications. In an accompanying commentary, Thomas Zollner and Khusru Asadullah from Schering AG in Berlin, Germany, discuss the underlying mechanisms of this approach and potential therapeutic applications.

TITLE: Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen


AUTHOR CONTACT:
Charles J. Dimitroff
Harvard Institutes of Medicine, Boston, Massachusetts, USA.
Phone: 617-525-5602
Fax: 617-525-5571
Email: cdimitroff@rics.bwh.harvard.edu

View the PDF of this article at: https://www.the-jci.org/press/19220.pdf

ACCOMPANYING COMMENTARY:
Selectin and selectin ligand binding: a bittersweet attraction

AUTHOR CONTACT:
Thomas M. Zollner
Schering AG, Berlin, Germany.
Phone: 49-30-468-17235
Fax: 49-30-468-97235
Email: Thomas.Zollner@schering.de

View the PDF of this commentary at: https://www.the-jci.org/press/19962.pdf

Brooke Grindlinger | EurekAlert!
Further information:
http://www.the-jci.org/press/19220.pdf
http://www.the-jci.org/press/19962.pdf

More articles from Health and Medicine:

nachricht Finding new clues to brain cancer treatment
21.02.2020 | Case Western Reserve University

nachricht UIC researchers find unique organ-specific signature profiles for blood vessel cells
18.02.2020 | University of Illinois at Chicago

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: High-pressure scientists in Bayreuth discover promising material for information technology

Researchers at the University of Bayreuth have discovered an unusual material: When cooled down to two degrees Celsius, its crystal structure and electronic properties change abruptly and significantly. In this new state, the distances between iron atoms can be tailored with the help of light beams. This opens up intriguing possibilities for application in the field of information technology. The scientists have presented their discovery in the journal "Angewandte Chemie - International Edition". The new findings are the result of close cooperation with partnering facilities in Augsburg, Dresden, Hamburg, and Moscow.

The material is an unusual form of iron oxide with the formula Fe₅O₆. The researchers produced it at a pressure of 15 gigapascals in a high-pressure laboratory...

Im Focus: From China to the South Pole: Joining forces to solve the neutrino mass puzzle

Study by Mainz physicists indicates that the next generation of neutrino experiments may well find the answer to one of the most pressing issues in neutrino physics

Among the most exciting challenges in modern physics is the identification of the neutrino mass ordering. Physicists from the Cluster of Excellence PRISMA+ at...

Im Focus: Therapies without drugs

Fraunhofer researchers are investigating the potential of microimplants to stimulate nerve cells and treat chronic conditions like asthma, diabetes, or Parkinson’s disease. Find out what makes this form of treatment so appealing and which challenges the researchers still have to master.

A study by the Robert Koch Institute has found that one in four women will suffer from weak bladders at some point in their lives. Treatments of this condition...

Im Focus: A step towards controlling spin-dependent petahertz electronics by material defects

The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.

Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Cancer cachexia: Extracellular ligand helps to prevent muscle loss

25.02.2020 | Life Sciences

High-pressure scientists in Bayreuth discover promising material for information technology

25.02.2020 | Information Technology

When plasmons reach atomic flatland

25.02.2020 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>